Cargando…
Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
AIMS: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition, and tissue congestion manifested by oedema is not present in all patients. We compared clinical characteristics, exercise capacity, and outcomes in patients with HFpEF with and without oedema. METHODS AND RESU...
Autores principales: | Fudim, Marat, Ashur, Nicolas, Jones, Aaron D., Ambrosy, Andrew P., Bart, Bradley A., Butler, Javed, Chen, Horng H., Greene, Stephen J., Reddy, Yogesh, Redfield, Margaret M., Sharma, Abhinav, Hernandez, Adrian F., Felker, Gary Michael, Borlaug, Barry A., Mentz, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835593/ https://www.ncbi.nlm.nih.gov/pubmed/33300277 http://dx.doi.org/10.1002/ehf2.13159 |
Ejemplares similares
-
High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network
por: Fudim, Marat, et al.
Publicado: (2018) -
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017) -
Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016) -
Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF
por: Fudim, Marat, et al.
Publicado: (2020) -
Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure
por: Sharma, Abhinav, et al.
Publicado: (2021)